Web Analytics
Cổ phiếu OCUL (NASDAQ) | OCULAR THERAPEUTIX INC – Phân tích Deepscope
MARKET

Select Market Data Region

OCUL — OCULAR THERAPEUTIX INC (Healthcare >> Biotechnology)

OCUL FAQ

What is OCUL's ROE?

OCULAR THERAPEUTIX INC reports a Return on Equity (ROE) of -49.95%.

What is OCUL's dividend yield?

OCULAR THERAPEUTIX INC offers a dividend yield of 0.00%.

What is OCUL's Deepscope Quality Score?

Deepscope rates OCUL's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy OCUL?

Deepscope's AI Timing Score for OCUL is 50 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does OCUL belong to?

OCULAR THERAPEUTIX INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

Stock Check   *Daily update data at 9:30 AM*
(Price: 2026-06-12 | FS: 2026-03-31)

OCUL

OCULAR THERAPEUTIX INC
USD 8.94
0.24 (2.76%) Day Change
0.13
D/E
-50.0%
ROE
-39.7%
ROA
0.00%
Div Yield
USD 8.94
Price
0.24 (2.76%)
Day Change
NEWS SCORE: 96

OCUL Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 23) và Thời điểm mua ...(Sign In to See)...

23

QUALITY

Signal
UNDERPERFORM
Signal Description
Company financial health is Not Good
Reason
Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Lịch sử ROE tương đối thấp
ROE đang giảm đáng kể
ROA quá thấp so với ROE
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Tăng trưởng ROA hiện tại đang dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal
OUTPERFORM
Signal Descri...
Good
Reason
Lorem ipsum dolor sit amet
Sign in to see timing analysis
Unlock timing signals and detailed reasons
Sign in free

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt lắm , và khả năng kiếm lợi nhuận Khá , ...

Yếu tố Chất lượng 39%
X
X
X
X
  In Recommendations? Not in any sections
  Select Rate 0.00 From 30 days period
  Watch Rate 0.00 From 30 days period
  News Score 96
  Magic Formula Rank by ROA
N/A
  Magic Formula Rank by ROE
N/A
  Magic Formula Rank by ROIC
N/A
  Price 8.94
  PBV / Sector
3.28 / 4.91
  Earning Per Share -1.36
  PE / Sector
N/A / 18.34
  PEG or PE/Growth / Sector
N/A / 0.61
  Average 1M Daily Value
20.89 M
GREAT
  Average 1W Daily Value
20.39 M
GREAT
Yếu tố Kỹ thuật 57%
  MACD
  MACD Signal
  MACD Divergence
  RSI
  Stochastic Oscillator K
  Stochastic Oscillator D
  ADX
  Avg 5 day Timing Score
Sức khỏe tài chính 50%
X
X
X
X
  DE / Sector
  DE Average / Sector
  DE Change Average (%) / Sector
  Current Ratio / Sector
  Current Ratio Average / Sector
  Current Ratio Change Average (%) / Sector
  Quick Ratio / Sector
  Quick Ratio Average / Sector
  Quick Ratio Change Average (%) / Sector
  FCF/Share / Sector
  FCF/Share Average / Sector
  FCF/Share Change Average (%) / Sector
Khả năng kiếm lợi nhuận 60%
X
X
X
X
X
X
X
  GPM (%) / Sector
  GPM Average (%) / Sector
  GPM Change Average (%) / Sector
  OPM (%) / Sector
  OPM Average (%) / Sector
  OPM Change Average (%) / Sector
  NPM (%) / Sector
-558.24 / 468.85
  NPM Average (%) / Sector
-330.24 / -1,531.69
  NPM Change Average (%) / Sector
49.43 / 5,028.65
GREAT
  Asset Turnover / Sector
  Asset Turnover Average / Sector
  Asset Turnover Change Average (%) / Sector
  ROA (%) / Sector
-39.66 / 31.69
  ROA Average (%) / Sector
-38.89 / -353.18
  ROA Change Average (%) / Sector
-0.60 / 5,214.65
  ROE (%) / Sector
-49.95 / 10.58
  ROE Average (%) / Sector
-88.27 / 27.64
  ROE Change Average (%) / Sector
-24.37 / 2,048.88
  ROIC (%) / Sector
  ROIC Average (%) / Sector
  ROIC Change Average (%) / Sector
Lợi tức cho nhà đầu tư 4%
X
  Dividend (%) / Sector
N/A / 0.05
  Dividend Average (%) / Sector
N/A / 16.49
  Dividend Change Average (%) / Sector
N/A / 5.15
Chi tiết đăng ký
X
  Analyze Date 2026-06-13 11:13:36
  Symbol OCUL
  Name OCULAR THERAPEUTIX INC
  Sector Healthcare >> Biotechnology
  Market NASDAQ
  Listed Shares 218.96 M
  Par Value N/A
  Calculated From Quarter
  Sign N/A
  Market Cap (M.USD) / Sector Average 1,904.96 / 9,034.83
Tin tức, Dự báo ước tính
  Estimation Consensus See at WSJ.com
  Full details See at WSJ.com
  Chart See in Chart feature
  News See at Yahoo Finance

Address: 14 Crosby Drive, Bedford, MA, United States, 01730

Phone: 781 357 4000

Website: https://www.ocutx.com

Employees: 325

Sector: Healthcare >> Biotechnology

Description: Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States. The company markets DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing AXPAXLI, an axitinib intravitreal hydrogel that is in phase 3 clinical trials for the treatment of wet age-related macular degeneration and non-proliferative diabetic retinopathy; OTX-TIC, a travoprost intracameral hydrogel, which has completed phase 2 clinical trials for the treatment of open-angle glaucoma or ocular hypertension. The company has a license agreement and collaboration with AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and OTX-TIC. Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.

ME vs SECTOR Healthcare >> Biotechnology

OCUL (ME)
Sector Peers
Bubble size = Market Cap

Click a bubble to view stock details  ·  Bubble size represents market capitalization share

News

Smart picks. Just WOW stocks/funds/ETFs. No noise like other tools.
OCUL
OCUL
USD 8.94 (2.76%)
+ Watch + Port Chart